The Drug Delivery Partnering Terms
and Agreements report provides comprehensive understanding and unprecedented
access to the drug delivery partnering deals and agreements entered into by the
worlds leading healthcare companies.
The report provides a detailed understanding
and analysis of how and why companies enter drug delivery partnering deals. The
majority of deals are discovery or development stage whereby the licensee
obtains a right or an option right to license the licensors drug delivery
technology. These deals tend to be multicomponent, starting with collaborative
R&D, and commercialization of outcomes.
Understanding the flexibility of a
prospective partner’s negotiated deals terms provides critical insight into the
negotiation process in terms of what you can expect to achieve during the
negotiation of terms. Whilst many smaller companies will be seeking details of
the payments clauses, the devil is in the detail in terms of how payments are
triggered – contract documents provide this insight where press releases do
not.
To Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis-details/drug-delivery-partnering-terms-and-agreements
This report contains over 2,000
links to online copies of actual drug delivery deals and contract documents as
submitted to the Securities Exchange Commission by companies and their
partners. Contract documents provide the answers to numerous questions about a
prospective partner’s flexibility on a wide range of important issues, many of
which will have a significant impact on each party’s ability to derive value
from the deal.
The initial chapters of this report
provide an orientation of drug delivery dealmaking and business
activities.
Chapter 1 provides an introduction to the report, whilst
Chapter 2 provides an overview of the trends in drug delivery
dealmaking since 2007, including details of average headline, upfront, milestone
and royalty terms.
Chapter 3 provides a review of the leading drug delivery deals since
2007. Deals are listed by headline value, signed by bigpharma, most active
bigpharma, and most active of all biopharma companies. Where the deal has an
agreement contract published at the SEC a link provides online access to the
contract.
Chapter 4 provides a comprehensive listing of the top 50
bigpharma companies with a brief summary followed by a comprehensive listing of
drug delivery deals as well as contract documents available in the public
domain. Where available, each deal title links via Weblink to an online version
of the actual contract document, providing easy access to each contract
document on demand.
Chapter 5 provides a comprehensive and detailed review of drug
delivery partnering deals signed and announced since 2007, where a contract
document is available in the public domain. The chapter is organized by company
A-Z, stage of development at signing, deal type (collaborative R&D,
co-promotion, licensing etc), and specific therapy focus. Each deal title links
via Weblink to an online version of the deal record and the contract document,
providing easy access to each contract document on demand.
To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/analysis/149827
Chapter 6 provides a comprehensive and detailed review of drug
delivery partnering deals organized by specific drug delivery technology type.
Each deal title links via Weblink to an online version of the deal record and
where available, the contract document, providing easy access to each contract
document on demand.
The report also includes numerous
tables and figures that illustrate the trends and activities in drug delivery
partnering and dealmaking since 2007.
In addition, a comprehensive
appendix is provided organized by drug delivery partnering company A-Z, deal
type definitions and drug delivery partnering agreements example. Each deal
title links via Weblink to an online version of the deal record and where
available, the contract document, providing easy access to each contract
document on demand.
In conclusion, this report provides
everything a prospective dealmaker needs to know about partnering in the
research, development and commercialization of drug delivery technologies and
products.
MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Email: sales@marketresearchreports.biz
Website: http://www.marketresearchreports.biz/
No comments:
Post a Comment